Zealand Pharma A/S (ZEAL) 2014年CSR报告「NASDAQ」.pdf

1、 STATUTORY REPORT ON CORPORATE SOCIAL RESPONSIBILITY (cf.SECTION 99a and 99b OF THE DANISH FINANCIAL STATEMENTS ACT)Statutory report on Corporate Social Responsibility(CSR)for the financial year 2014 cf.Section 99a and 99b of the Danish Financial Statements Act(in Danish“Lovpligtig redegrelse for sa

2、mfundsansvar,jf.rsregnskabslovens 99a og 99b”).This report is a supplement to the Managements review in the Zealand Pharma A/S Annual Report 2014 covering the period 1 January-31 December 2014.CEO statement Zealand Pharma A/S(Zealand)has made a pledge to formalize and disclose the core values that h

3、ave underwritten our success,in which corporate social responsibility has played an important part.To acknowledge and further develop this facet of our business,Zealand draws from the most pertinent elements of some of the most widely implemented CSR initiatives in the world,notably the Global Repor

4、ting Initiative and the United Nations Global Compact.Zealand has found in these two systems complementary frameworks for both guiding and reporting its CSR activities along several principles in the areas of human rights,the environment,labour and anti-corruption.In addition to these,we have supple

5、mented a provisional category for animal rights owing to the unique exigencies of our industry.Zealands CSR report does not reflect a static system of initiatives and policies.It is an ongoing process that adapts to accommodate new ideas and activities to keep the company up to date with the develop

6、ments within this area.CSR Steering Group&Strategy To improve the transparency of its corporate social responsibility,the company has elevated CSR questions from the CSR Steering Group to Zealands Executive Management.The following focus areas have been considered important to Zealands business and